Clinical Trial Update: Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy [Phase 2]

View source ↗

Summary

Phase 2 study of EDG-5506 in children and adolescents with Duchenne muscular dystrophy previously treated with gene therapy. The trial is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• EDG-5506 (EDG-5506)

Snippet

Sponsor: Edgewise Therapeutics, Inc. | Conditions: Duchenne Muscular Dystrophy | Phase 2 | Status: ACTIVE_NOT_RECRUITING